Birdwatch Archive

Birdwatch Note Rating

2024-04-14 10:13:06 UTC - HELPFUL

Rated by Participant: 6745B794E9C46A45ABF33E250B5053EC684C28F888355F682E5F8899E2F65E28
Participant Details

Original Note:

É verdade que o medicamento Venvanse vai perder a patente em 2024. Porém o medicamento Juneve é apenas um semelhante, não pode ser considerado genérico, pois apesar da mesma composição não são utilizadas para os mesmos tratamentos https://site.cff.org.br/noticia/Noticias-gerais/15/03/2024/farmaceutica-deve-perder-patente-e-venvanse-pode-ganhar-versao-generica-e-mais-barata

All Note Details

Original Tweet

All Information

  • noteId - 1779335238990151845
  • participantId -
  • raterParticipantId - 6745B794E9C46A45ABF33E250B5053EC684C28F888355F682E5F8899E2F65E28
  • createdAtMillis - 1713089586133
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 17793352389901518456745B794E9C46A45ABF33E250B5053EC684C28F888355F682E5F8899E2F65E28